CO2 Inhalation Device for Central Sleep Apnea

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current carbon dioxide inhalation treatments for central sleep apnea are ineffective due to difficulties in titrating and maintaining the concentration of inspired CO2, causing discomfort and inadequate correction of sleep apnea, especially in heart failure patients, as existing devices rely on airflow sensors and thoracoabdominal bands that are uncomfortable and lack real-time CO2 titration capabilities.

Innovation Solution

A carbon dioxide inhalation treatment device comprising a blower, gas cylinder, mixing chamber, mask, and detection mechanism using EEG and EMG recording electrodes to determine the optimal CO2 concentration, ensuring stable and moderate CO2 delivery without causing arousal, featuring a loosely connected mask and alarm system for safety, and a flow meter for precise CO2 adjustment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the concentration of inhaled carbon dioxide is increased to effectively correct central sleep apnea, then the therapeutic effect is improved, but the risk of causing arousal and aggravating the condition increases

Engineering Contradiction:
Improvetherapeutic effectVSAvoidarousal risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent employs a feedback control system using a capnograph to continuously monitor end-tidal CO2 levels and adjust the CO2 concentration delivered to the patient in real-time. This closed-loop feedback mechanism ensures that the therapeutic effect is maintained while preventing excessive CO2 concentration that could cause arousal, thus resolving the contradiction between effectiveness and safety.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system dynamically adjusts the concentration parameter of inhaled CO2 based on real-time physiological monitoring. By changing the CO2 concentration parameter adaptively rather than using fixed high concentrations, the system achieves effective correction of central sleep apnea while staying below the threshold that triggers arousal, thereby resolving the contradiction.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If traditional airflow sensors and thoracoabdominal bands are used to detect apnea, then apnea detection capability is achieved, but patient comfort deteriorates and sleep is affected

Engineering Contradiction:
Improveapnea detection capabilityVSAvoidpatient comfort
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent extracts and eliminates the uncomfortable components (thoracoabdominal bands and nasal airflow sensors) from the detection system. Instead, it uses only the capnograph to monitor CO2 levels and detect apnea events, thereby maintaining measurement precision while significantly improving patient comfort and sleep quality.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces the mechanical detection system (bands and sensors that physically contact and constrain the patient) with a gas analysis-based detection system using capnography. This substitution eliminates the mechanical discomfort while preserving the ability to detect apnea events through physiological parameter monitoring.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If real-time titration of CO2 concentration is implemented to maintain optimal therapeutic levels, then treatment precision is improved, but device complexity increases

Engineering Contradiction:
Improvetitration precisionVSAvoiddevice complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent uses a feedback control system where the capnograph continuously monitors end-tidal CO2 levels and provides real-time information to adjust the CO2 concentration delivered. This feedback mechanism enables precise titration of CO2 levels without requiring overly complex manual adjustment mechanisms, as the system self-regulates based on monitored physiological parameters.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs automatic self-adjustment of CO2 concentration based on real-time capnographic monitoring. The device monitors its own output and automatically titrates the CO2 delivery to maintain optimal therapeutic levels, eliminating the need for complex external control mechanisms and reducing overall system complexity while maintaining high precision.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS10898669B2Carbon dioxide inhalation treatment device for central sleep apnea
Publication Date: 2021.01.26 LUO YUANMING
  • US10898669B2 patent drawing
  • US10898669B2 patent drawing

AI summary

The present invention discloses a carbon dioxide inhalation treatment device for central sleep apnea comprising a blower, a gas cylinder filled with carbon dioxide (CO2), an airbag, a mask, and a detection mechanism for detecting the central apnea by measuring the electromyographic activity of the chest wall muscles. The mask is provided with multiple holes providing a communication between the inside and outside of the mask in order to prevent any sense of resistance of breathing and to provide greater control of inspired CO2. Inspired CO2 from a gas mixture containing also a minimum 20% O2 is driven by air using a blower into a mixing chamber. This carbon dioxide inhalation treatment device for central sleep apnea can provide a stable, mild level of carbon dioxide for patients with central sleep apnea, thus by preserving respiratory drive correcting central sleep apnea without increasing the arousal and microarousal frequency.